Luye Pharma Group Stock Market Value
| LYPHF Stock | USD 0.34 0.03 9.68% |
| Symbol | Luye |
Luye Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Luye Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Luye Pharma.
| 11/28/2023 |
| 11/22/2024 |
If you would invest 0.00 in Luye Pharma on November 28, 2023 and sell it all today you would earn a total of 0.00 from holding Luye Pharma Group or generate 0.0% return on investment in Luye Pharma over 360 days. Luye Pharma is related to or competes with Astellas Pharma, Sanofi ADR, Amarin PLC, Novartis, Scilex Holding, Biogen, and Gilead Sciences. Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide More
Luye Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Luye Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Luye Pharma Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0312 | |||
| Maximum Drawdown | 9.68 |
Luye Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Luye Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Luye Pharma's standard deviation. In reality, there are many statistical measures that can use Luye Pharma historical prices to predict the future Luye Pharma's volatility.| Risk Adjusted Performance | 0.0975 | |||
| Jensen Alpha | 0.1465 | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | (1.38) |
Luye Pharma Group Backtested Returns
At this point, Luye Pharma is extremely dangerous. Luye Pharma Group has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We have found nineteen technical indicators for Luye Pharma, which you can use to evaluate the volatility of the firm. Please verify Luye Pharma's Risk Adjusted Performance of 0.0975, standard deviation of 1.19, and Mean Deviation of 0.2888 to check out if the risk estimate we provide is consistent with the expected return of 0.15%. Luye Pharma has a performance score of 9 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.0992, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Luye Pharma are expected to decrease at a much lower rate. During the bear market, Luye Pharma is likely to outperform the market. Luye Pharma Group right now secures a risk of 1.22%. Please verify Luye Pharma Group standard deviation and the relationship between the total risk alpha and period momentum indicator , to decide if Luye Pharma Group will be following its current price movements.
Auto-correlation | 0.75 |
Good predictability
Luye Pharma Group has good predictability. Overlapping area represents the amount of predictability between Luye Pharma time series from 28th of November 2023 to 26th of May 2024 and 26th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Luye Pharma Group price movement. The serial correlation of 0.75 indicates that around 75.0% of current Luye Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Luye Pharma Group lagged returns against current returns
Autocorrelation, which is Luye Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Luye Pharma's pink sheet expected returns. We can calculate the autocorrelation of Luye Pharma returns to help us make a trade decision. For example, suppose you find that Luye Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Luye Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Luye Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Luye Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Luye Pharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Luye Pharma Lagged Returns
When evaluating Luye Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Luye Pharma pink sheet have on its future price. Luye Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Luye Pharma autocorrelation shows the relationship between Luye Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Luye Pharma Group.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Luye Pink Sheet
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.